Metastatic Liver Cancer Pipeline Insight 2024, Featuring Key Players Oncorus, Sirnaomics, Codiak BioSciences, RemeGen, Amarin, Medivir, AstraZeneca, Amal Therapeutics and Boehringer Ingelheim
April 15, 2024 07:20 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Metastatic Liver Cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides...
Global CAR-T Cell Therapy Market Expected to Surge to USD 34.04 Billion by 2034 with a CAGR of 23.33%
March 27, 2024 08:50 ET
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global...
France CAR-T Cell Therapy Market Anticipates Impressive Growth Amid Advances in Personalized Medicine and Increase in Hematological Malignancies
February 12, 2024 04:32 ET
|
Research and Markets
Dublin, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The "France CAR-T Cell Therapy Market, By Region, By Competition Forecast & Opportunities, 2018-2028F" report has been added to ...
Global CAR-T Cell Therapy Market Report 2024-2034: Accelerated Growth Fueled by Intensive R&D, Growing Medical Recognition, and Fast Track Designation Regulatory Approvals
January 24, 2024 14:23 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. With the...
Global CAR T-Cell Therapy Research Report 2023: Market Poised for Substantial Growth by 2030, Driven by Advancements in Cancer Treatment and Increasing Incidence Rates
January 24, 2024 04:13 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global CAR T-Cell Therapy Market 2030 by Drug type, Indication, Target Antigen, End-user and Region - Partner & Customer Ecosystem Competitive...
Global CAR T-Cell Therapy Market to Surpass $15 Billion by 2030, Driven by Growing Prevalence of Multiple Myeloma and Lymphoma
December 08, 2023 08:18 ET
|
Research and Markets
Dublin, Dec. 08, 2023 (GLOBE NEWSWIRE) -- The "CAR T-cell Therapy Market Size, Share & Trends Analysis Report by Product (Abecma, Breyanzi), By Disease Indication (Lymphoma, Leukemia, Multiple...
[NEW REPORT] CAR-T Cell Therapy Market is estimated to be US$ 7.0 billion by 2032; Growing Prevalence of Cancer Disease to Foster Market Growth - BY PMI
May 04, 2023 11:05 ET
|
PMI
Covina, May 04, 2023 (GLOBE NEWSWIRE) -- CAR-T Cell Therapies has entered in mainstream of cancer treatment with innovation and are widely available in U.S. and other regions. Six CAR-T Cell...
T-cell Therapy Global Market Report 2023: Rising Global Investments in Gene and Cell Therapy Arena Presents Opportunities
March 13, 2023 05:18 ET
|
Research and Markets
Dublin, March 13, 2023 (GLOBE NEWSWIRE) -- The "T-cell Therapy Market Size, Share & Trends Analysis Report By Modality, By Therapy (CAR T-cell, Tumor-Infiltrating Lymphocytes), By Indication...
Stem Cell Therapy Market Size Worth USD 92.08 Million by 2030 at 16.20% CAGR – Report by Market Research Future (MRFR)
March 06, 2023 09:45 ET
|
Market Research Future
New York, USA, March 06, 2023 (GLOBE NEWSWIRE) -- Stem Cell Therapy Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), "Stem Cell Therapy...
Global Cancer Immunotherapy Market to Surpass US$ 216,792.7 Million by 2030, Says Coherent Market Insights (CMI)
January 23, 2023 09:00 ET
|
CMI
Burlingame, Jan. 23, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global Cancer Immunotherapy Market is estimated to be valued at US$ 102,095.5 million in 2022 and is expected to...